Dramamine
FDA Label NDC 67751-170

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Navajo Manufacturing Company Inc. for the product Dramamine (NDC 67751-170). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding active ingredient (in each tablet), purpose, use, do not use, ask a doctor before use if you have, ask a doctor or pharmacist before use if, when using this product, if pregnant or breast-feeding,, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Active Ingredient (In Each Tablet)

Dimenhydrinate 50 mg

Purpose

Antiemetic

Use

for prevention and treatment of these symptoms associated with motion sickness:
• nausea • vomiting • dizziness

Do Not Use

for children under 2 years of age unless directed by a doctor

Ask A Doctor Before Use If You Have

• a breathing problem such as emphysema or chronic bronchitis
• glaucoma
• trouble urinating due to an enlarged prostate gland

Ask A Doctor Or Pharmacist Before Use If

you are taking sedatives or tranquilizers

When Using This Product

• marked drowsiness may occur
• avoid alcoholic drinks
• alcohol, sedatives, and tranquilizers may increase drowsiness
• be careful when driving a motor vehicle or operating machinery

If Pregnant Or Breast-Feeding,

ask a doctor before use.

Keep Out Of Reach Of Children.

In case of accidental overdose, get medical help or contact a Poison Control Center (1-800-222-1222) right away.

Directions

to prevent motion sickness, the first dose should be taken 1/2 to 1 hour before starting activity
to prevent or treat motion sickness:

 adults and children 12 years and over

• take 1 to 2 chewable tablets every 4-6 hours 

• do not take more than 8 chewable tablets in 24 hours, or as directed by a doctor

 children 6 to under 12 years

• give 1/2 to 1 chewable tablet every 6-8 hours

• do not give more than 3 chewable tablets in 24 hours, or as directed by a doctor

 children 2 to under 6 years

• give 1/2 chewable tablet every 6-8 hours

• do not give more than 1-1/2 chewable tablets in 24 hours, or as directed by a doctor

Other Information

Phenylketonurics: contains phenylalanine 0.75 mg per tablet
• store at room temperature 20°-25°C (68°- 77°F)
• do not use if pouch is opened
• see pouch for lot number and expiration date

Inactive Ingredients

anhydrous citric acid, aspartame, FD&C yellow #6 aluminum lake, flavors, magnesium stearate, maltodextrin, methacrylic acid copolymer, modified starch, sorbitol

Questions Or Comments?

call 1-800-382-7219

Package Labeling:

Dramamine (Dramamine)

Dramamine (Dramamine)

* Please review the disclaimer below.